Skip to main content
PMC home page
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1993 Jun;74(3):275–281.

Cardioprotective action of sodium gamma-hydroxybutyrate against isoproterenol induced myocardial damage.

A Kolin 1, A Brezina 1, M Mamelak 1, E Pandula 1
PMCID: PMC2002167  PMID: 8334077

Abstract

In this study, the effects of graded doses of isoproterenol (IP) on the heart were examined in untreated gerbils and in gerbils anaesthetized with gamma-hydroxybutyrate (GHB), an endogenous metabolite with energy sparing properties. We were interested in the cardioprotective potential of GHB. IP was administered intraperitoneally in doses of 0.1, 0.3. 2.5 and 10.0 mg/kg to different groups of gerbils. Half the gerbils in each treatment group received 500 mg/kg of GHB 30 min before IP, and 250 mg/kg at three subsequent 2-hour intervals. The remaining gerbils in each treatment group received saline at these time points. The animals were sacrificed after 8 hours. The accumulation of neutral fat droplets in the sarcoplasm was the most consistent effect of IP. The highest dose also produced some scattered myofibre death. The accumulation of fat in the cells could be estimated semi-quantitatively using a histochemical reaction for succinic dehydrogenase, and the volume of fat could be measured more accurately by electron microscopic morphometry. These measurements showed that IP produced a three to five-fold increase in sarcoplasmic fat volume. GHB either abolished or significantly reduced the accumulation of fat and it also completely prevented the myofibre death caused by the highest doses of IP. This cardioprotective effect of GHB was independent of its hypothermic action. Based on this experience, ultrastructural morphometry of sarcoplasmic fat appears to be a promising method for evaluating cardioprotective measures.

Full text

PDF
275

Images in this article

277Figure 1
on p.277
278Figure 2
on p.278
279Figure 3
on p.279
280Figure 4
on p.280

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyd A. J., Sherman I. A., Saibil F. G., Mamelak M. The protective effect of gamma-hydroxybutyrate in regional intestinal ischemia in the hamster. Gastroenterology. 1990 Sep;99(3):860–862. doi: 10.1016/0016-5085(90)90982-7. [DOI] [PubMed] [Google Scholar]
  2. Boyd A. J., Sherman I. A., Saibil F. G. The cardiovascular effects of gamma-hydroxybutyrate following hemorrhage. Circ Shock. 1992 Oct;38(2):115–121. [PubMed] [Google Scholar]
  3. CHAPPEL C. I., RONA G., BALAZS T., GAUDRY R. Severe myocardial necrosis produced by isoproterenol in the rat. Arch Int Pharmacodyn Ther. 1959 Oct 1;122:123–128. [PubMed] [Google Scholar]
  4. Cebelin M. S., Hirsch C. S. Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries. Hum Pathol. 1980 Mar;11(2):123–132. doi: 10.1016/s0046-8177(80)80129-8. [DOI] [PubMed] [Google Scholar]
  5. Connor R. C. Heart damage associated with intracranial lesions. Br Med J. 1968 Jul 6;3(5609):29–31. doi: 10.1136/bmj.3.5609.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FERRANS V. J., HIBBS R. G., BLACK W. C., WEILBAECHER D. G. ISOPROTERENOL-INDUCED MYOCARDIAL NECROSIS. A HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDY. Am Heart J. 1964 Jul;68:71–90. doi: 10.1016/0002-8703(64)90242-x. [DOI] [PubMed] [Google Scholar]
  7. KOLIN A., KVASNICKA J., KRALOVE H. PSEUDOINFARCTION PATTERN OF THE QRS COMPLEX IN EXPERIMENTAL CARDIAC HYPOXIA INDUCED BY NORADRENALIN. ELECTROCARDIOGRAPHIC AND HISTOCHEMICAL STUDY. Cardiologia. 1963;43:362–370. [PubMed] [Google Scholar]
  8. Kakari S. Observations on the use of nitro blue tetrazolium in the detection of early myocardial changes. Histochem J. 1970 Nov;2(6):453–477. doi: 10.1007/BF01003125. [DOI] [PubMed] [Google Scholar]
  9. Kolin A., Brezina A., Kellen J. A., Lewis A. J., Norris J. W. Reversible myocardial damage in gerbil brain ischaemia and its prevention by beta-adrenergic blockade. Br J Exp Pathol. 1988 Oct;69(5):621–630. [PMC free article] [PubMed] [Google Scholar]
  10. Kolin A., Brezina A., Lewis A. J., Norris J. W. Quantitative evaluation of myocardial injury induced by acute cerebral ischaemia and its prevention by beta 1-adrenergic blockade. An ultrastructural morphometry study. Br J Exp Pathol. 1989 Dec;70(6):659–667. [PMC free article] [PubMed] [Google Scholar]
  11. Kolin A., Brezina A., Mamelak M. Cardioprotective effects of sodium gamma-hydroxybutyrate (GHB) on brain induced myocardial injury. In Vivo. 1991 Jul-Aug;5(4):429–431. [PubMed] [Google Scholar]
  12. Kolin A., Norris J. W. Myocardial damage from acute cerebral lesions. Stroke. 1984 Nov-Dec;15(6):990–993. doi: 10.1161/01.str.15.6.990. [DOI] [PubMed] [Google Scholar]
  13. Lavyne M. H., Hariri R. J., Tankosic T., Babiak T. Effect of low dose gamma-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat. Neurosurgery. 1983 Apr;12(4):430–434. doi: 10.1227/00006123-198304000-00010. [DOI] [PubMed] [Google Scholar]
  14. Liedtke A. J. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis. 1981 Mar-Apr;23(5):321–336. doi: 10.1016/0033-0620(81)90019-0. [DOI] [PubMed] [Google Scholar]
  15. MacMillan V. The effects of gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain. Brain Res. 1978 May 5;146(1):177–187. doi: 10.1016/0006-8993(78)90229-9. [DOI] [PubMed] [Google Scholar]
  16. Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev. 1989 Winter;13(4):187–198. doi: 10.1016/s0149-7634(89)80053-3. [DOI] [PubMed] [Google Scholar]
  17. SZAKACS J. E., CANNON A. L-Norepinephrine myocarditis. Am J Clin Pathol. 1958 Nov;30(5):425–434. doi: 10.1093/ajcp/30.5.425. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES